Selective primer unblocking of carbovir, lamivudine, tenofovir and zidovudine by wild-type HIV reverse transcriptase with nucleotide and deoxynucleotide triphosphates

被引：0
|
作者：
Gerondelis, P [1 ]
Underwood, MR [1 ]
Lanier, ER [1 ]
机构：
[1] GlaxoSmithKline Inc, Dept Int Clin Virol, Res Triangle Pk, NC USA
来源：
ANTIVIRAL THERAPY | 2004年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：U37 / U38
页数：2
相关论文
共 50 条
  • [1] Inhibition of purified recombinant reverse transcriptase from wild-type and zidovudine-resistant clinical isolates of human immunodeficiency virus type 1 by zidovudine, stavudine, and lamivudine triphosphates
    Duan, CY
    Poticha, D
    Stoeckli, TC
    Petropoulos, CJ
    Whitcomb, JM
    McHenry, CS
    Kuritzkes, DR
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (10): : 1336 - 1340
  • [2] Effects of specific zidovudine resistance mutations and substrate structure on nucleotide-dependent primer unblocking by human immunodeficiency virus type I reverse transcriptase
    Meyer, PR
    Matsuura, SE
    Tolun, AA
    Pfeifer, I
    So, AG
    Mellors, JW
    Scott, WA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) : 1540 - 1545
  • [3] Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism
    Meyer, PR
    Matsuura, SE
    So, RG
    Scott, WA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) : 13471 - 13476
  • [4] A mechanism of AZT resistance: An increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase
    Meyer, PR
    Matsuura, SE
    Mian, AM
    So, AG
    Scott, WA
    MOLECULAR CELL, 1999, 4 (01) : 35 - 43
  • [5] Nucleotide analogue binding, catalysis and primer unblocking in the mechanisms of HIV-1 reverse transcriptase-mediated resistance to nucleoside analogues
    Selmi, B
    Deval, J
    Boretto, J
    Canard, B
    ANTIVIRAL THERAPY, 2003, 8 (02) : 143 - 154
  • [6] Effects of mutations associated with suppression of zidovudine resistance in HIV-1 reverse transcriptase on removal of tenofovir from blocked primer/template
    Espili, NH
    Bergroth, T
    Pavlova, A
    Shao, XW
    McKenna, P
    Sönnerborg, A
    Lennerstrand, J
    ANTIVIRAL THERAPY, 2004, 9 (04) : U36 - U37
  • [7] Lamivudine resistance of HIV type 1 does not delay development of resistance to nonnucleoside HIV type 1-specific reverse transcriptase inhibitors as compared with wild-type HIV type 1
    Jonckheere, H
    Witvrouw, M
    De Clercq, E
    Anné, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (03) : 249 - 253
  • [8] Sensitivity and resistance to (+)-calanolide A of wild-type and mutated forms of HIV-1 reverse transcriptase
    Quan, YD
    Motakis, D
    Buckheit, R
    Xu, ZQ
    Flavin, MT
    Parniak, MA
    Wainberg, MA
    ANTIVIRAL THERAPY, 1999, 4 (04) : 203 - 209
  • [9] Covalent Inhibition of Wild-Type HIV-1 Reverse Transcriptase Using a Fluorosulfate Warhead
    Ippolito, Joseph A.
    Niu, Haichan
    Bertoletti, Nicole
    Carter, Zachary J.
    Jin, Shengyan
    Spasov, Krasimir A.
    Cisneros, Jose A.
    Valhondo, Margarita
    Cutrona, Kara J.
    Anderson, Karen S.
    Jorgensen, William L.
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (02): : 249 - 255
  • [10] Structures of wild-type and AZT-Resistant HIV-1 reverse transcriptase complexed with AZTppppA yield insights into the nucleotide excision mechanism
    Tu, Xiongying
    Sarafianos, Stefan G.
    Han, Qianwei
    Das, Kalyan
    Hou, Xiaorong
    Bauman, Joe
    Clark, Arthur D.
    Gaffney, Babara L.
    Jones, Roger A.
    Boyer, Paul L.
    Hughes, Stephen H.
    Arnold, Eddy
    FASEB JOURNAL, 2007, 21 (05): : A640 - A640
12345